Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: Results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) Study

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Mallaina, Pablo ^a   Lionis, Christos ^b   Rol, Hugo ^c   Imperiali, Renzo ^d   Burgess, Andrew ^e   Nixon, Mark ^e   Malvestiti, Franco Mondello ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b UNIVERSITY OF CRETE   (Greece)

^c Bennebroek Primary Care Center   (Netherlands)

^d Primary Care Varese ASL   (Italy)

^e IQVIA   (United States)

Author keywords

ASPIRE; Cardiovascular; Cessation; Diseases; Europe; Framingham; Model; Progetto; SCORE; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL COMPETENCE; EUROPE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATIENT ATTITUDE; PHYSICIAN; PRIMARY HEALTH CARE; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; STATISTICS; UTILIZATION REVIEW; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CLINICAL COMPETENCE; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIANS; PRIMARY HEALTH CARE; RISK ASSESSMENT; SMOKING; SMOKING CESSATION;

MLCS; MLOWN;

EID: 84876173284     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-362     Document Type: Article

References (32)

1. World Health Organization: WHO Report on the Global Tobacco Epidemic, World Health Organization: WHO Report on the Global Tobacco Epidemic 2008 [ http://www.who.int/tobacco/mpower/en/ ]
2. European Heart Network, CVD Statistics [ http://www.ehnheart.org/cvd- statistics.html ]
3. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG, Eur Heart J 1999 20 344 53 10.1053/euhj.1998.1194 10206381
4. Guidelines for the Management of Arterial Hypertension. Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J Hypertens 2007 25 87 1105 10.1097/01.hjh.0000254375.73241.e2 17143178
5. Guidelines on diabetes, pre-diabetes and cardiovascular disease: full text. Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD), Eur Heart J 2007 9 1 74 10.1016/j.ejheart.2006.12.005
6. INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, Lancet 2004 364 937 952 10.1016/S0140-6736(04)17018-9 15364185
7. National Cholesterol Education Program, Risk Assessment Tool for Estimating 10-year Risk of Developing Hard CHD (Myocardial Infarction and Coronary Death) [ http://hp2010.nhlbihin.net/atpIII/calculator.asp?usertype=prof ]
8. Prediction of coronary heart disease using risk factor categories. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB, Circulation 1998 97 18 1837 47 10.1161/01.CIR.97.18.1837 9603539
9. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB, Circulation 2008 117 743 53 10.1161/CIRCULATIONAHA. 107.699579 18212285
10. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P, JAMA 2001 286 2 180 187 10.1001/jama.286.2.180 11448281
11. Intermittent claudication. A risk profile from the Framingham Heart Study. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF, Circulation 1997 96 1 44 9 10.1161/01.CIR.96.1.44 9236415
12. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC, Am Heart J 2000 139 2 Pt 1 272 281 10650300
13. SCORE project group: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, Eur Heart J 2003 24 11 987 1003 10.1016/S0195-668X(03)00114-3 12788299
14. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte Op Reimer WJM, Vrints C, Wood D, Luis Zamorano J, Zannad F, Eur Heart J 2012 33 1635 1701 22555213
15. La valutazione del rischio cardiovascolare globale assoluto: il punteggio individuale del Progetto CUORE. Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R, Cesana G, Giampaoli S, per il Gruppo di Ricerca del Progetto CUORE, Ann 1st Super Sanita 2004 40 4 393 399
16. Self-reported smoking cessation activities among Swiss primary care physicians. Sadowski J, Ruffieux C, Cornuz J, BMC Fam Pract 2009 10 22 10.1186/1471-2296-10-22 19320964
17. gp-training.net-a GP education and training resource, Smoking cessation facts [ http://www.gp-training.net/protocol/misc/smoking/facts.htm ]
18. General practitioners' views on and referral to NHS smoking cessation services. McEwen A, West R, Owen L, Raw M, Public Health 2005 119 4 262 268 10.1016/j.puhe.2004.05.016 15733685
19. An evaluation of general practitioners' interactions with the smoking cessation service and the impact of a desktop resource on the service. O'Sullivan J, MA thesis Cork: University College Cork Department of Epidemiology and Public Health. National University of Ireland 2006
20. Prevalence of smoking in physicians and medical students, and the generation effect in The Netherlands. Dekker HM, Looman CWN, Adriaanse HP, van der Maas PJ, Soc Sci Med 1993 36 6 817 822 10.1016/0277-9536(93)90042-3 8480226
21. PESCE European Research Team: Factors influencing European GPs' engagement in smoking cessation: a multi-country literature review. Stead M, Angus K, Holme I, Cohen D, Tait G, Br J GenPract 2009 59 566 682 690
22. Physician's involvement in the smoking cessation process of their patients. Results of a 1998 survey among 4,643 Belgian physicians. Prignot J, Bartsch P, Vermeire P, Jamart J, Wanlin M, Uydebrouck M, Thijs J, Acta Clinica Belgica 2000 55 5 266 275 11109641
23. Smoking cessation activity within primary health care in Scotland: present constraints and their implications. Lennox AS, Taylor R, Health Education Journal 1995 54 1 48 60 10.1177/001789699505400106
24. EUROPREV network: Prevention and health promotion in clinical practice: the views of general practitioners in Europe. Brotons C, Björkelund C, Bulc M, Ciurana R, Godycki-Cwirko M, Jurgova E, Kloppe P, Lionis C, Mierzecki A, Piñeiro R, Pullerits L, Sammut MR, Sheehan M, Tataradze R, Thireos EA, Vuchak J, Prev Med 2005 40 595 601 10.1016/j.ypmed.2004.07.020 15749144
25. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO, Br J Addict 1991 Sep 86 9 1119 1127 10.1111/j.1360-0443. 1991.tb01879.x
26. Do patients with chronic obstructive pulmonary disease receive smoking cessation advice and interventions in rural Crete? Report from a medical audit study. Kotsoni C, Antonakis N, Markaki A, Lionis C, Aust J Rural Health 2008 Dec 16 6 385 6 10.1111/j.1440-1584.2008.01024.x
27. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Revised 2011). Global initiative for chronic obstructive lung disease (GOLD)
28. Seeking prescribing patterns in rural Crete: a pharmacoepidemiological study from a primary care area. Antonakis N, Xylouri I, Alexandrakis M, Cavoura C, Lionis C, Rural and Remote Health 2006 6 488 16464135
29. Cardiovascular risks associated with smoking: a review for clinicians. Tonstad S, Johnston A, Eur J Cardiovasc Prev Rehabil 2006 Aug 13 4 507 14 10.1097/01.hjr.0000214609.06738.62
30. INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, The Lancet 2004 364 9438 937 952 10.1016/S0140-6736(04)17018-9
31. Action on Smoking and Health, Stopping smoking: the benefits and aids to quitting [ http://ash.org.uk/files/documents/ASH-116.pdf ]
32. Treating Tobacco Use and Dependence, Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME, Public Health Service 2008